Relay Therapeutics, Inc. RLAY Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s operating lease liabilities?
- Relay Therapeutics, Inc. (RLAY) reported operating lease liabilities of $27.68M in Q1 2026.
- How has Relay Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s operating lease liabilities decreased by 32.9% year-over-year, from $41.23M to $27.68M.
- What is the long-term trend for Relay Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s operating lease liabilities has grown at a 4.6% compound annual growth rate (CAGR), from $22.9M to $28.69M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.